Antihypertensive Efficacy and Safety of Candesartan/HCT 32/25 mg in Comparison With Individual Components and Placebo
Clinical trial NCT00434967 · COMPLETED
Trial details
- NCT number
- NCT00434967
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-01-01
- Primary completion
- 2008-01-01
- Enrollment
- 2207
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.